| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.0004 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0004 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0004 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |